GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Rayont Inc (OTCPK:RAYT) » Definitions » ROE % Adjusted to Book Value

Rayont (Rayont) ROE % Adjusted to Book Value : -2.82% (As of Mar. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Rayont ROE % Adjusted to Book Value?

Rayont's ROE % for the quarter that ended in Mar. 2023 was -17.71%. Rayont's PB Ratio for the quarter that ended in Mar. 2023 was 6.27. Rayont's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2023 was -2.82%.

Rayont ROE % Adjusted to Book Value Historical Data

The historical data trend for Rayont's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rayont ROE % Adjusted to Book Value Chart

Rayont Annual Data
Trend Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Jun22
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -117.00 -8.10 0.99

Rayont Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 7.21 17.80 -9.17 -2.82

Competitive Comparison of Rayont's ROE % Adjusted to Book Value

For the Packaged Foods subindustry, Rayont's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rayont's ROE % Adjusted to Book Value Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Rayont's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Rayont's ROE % Adjusted to Book Value falls into.


Rayont ROE % Adjusted to Book Value Calculation

Rayont's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=8.89% / 8.96
=0.99%

Rayont's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-17.71% / 6.27
=-2.82%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rayont ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Rayont's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Rayont (Rayont) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Rayont Inc (OTCPK:RAYT) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
SHRG NXMH SMFL GLUC RTON RIBT BDPT NGTF MTTCF BSFC XSWX:NESN KHC GIS XPAR:BN SHSE:603288 NSE:NESTLEIND SZSE:300999 SHSE:600887 TSE:2802 LSE:ABF
Traded in Other Exchanges
N/A
Address
228 Hamilton Avenue, 3rd Floor, Palo Alto, CA, USA, 94301
Website
https://www.rayont.com
Rayont Inc is a clinical-stage life sciences company that holds the license for registering and commercializing Photosoft technology for the treatment of all cancers. This technology is an improved next-generation Photodynamic Therapy (PDT) that uses non-toxic photosensitizers and visible light in combination with oxygen to produce cytotoxic-reactive oxygen that kills malignant cells, shuts down tumors, and stimulates the immune system. It has been licensed in Australia, New Zealand, China, Malaysia, and Sub-Sahara Africa. It has generated revenue from digital learning solutions provided by Rayont Technologies.
Executives
Meng Leong Liew director 1313 N. GRAND AVE. #16, WALNUT CA 91789
Kha Foo Chin director, 10 percent owner, officer: President, Treasurer ROOM 1217 NORTH TOWER, CONORDIA PLAZA, NO 1 SCIENCE MUSEUM RD., TSIM SHA TSUI E, KOWLOON K3 NA